Inventor · disambiguated record
Jan Borén
Also filed as: BOREN JAN · BORÉN JAN
6 granted patents·4 pending applications·15 citations·filing 1999–2022
73Inventor score
Top patents by PatentIndex Score
10 records- 0162US11813236B2Substances for treatment of fatty liver-related conditionsSCANDIBIO THERAPEUTICS AB·Filed 2021·Granted Nov 14, 2023·0 cites·21 claims
- 0256US11141396B2Substances for treatment of fatty liver-related conditionsSCANDIBIO THERAPEUTICS AB·Filed 2017·Granted Oct 12, 2021·0 cites·12 claims
- 0355US6579682B1Methods and tools for identifying compounds which modulate atherosclerosis by impacting LDL-proteoglycan bindingUNIV CALIFORNIA·Filed 1999·Granted Jun 17, 2003·15 cites·5 claims
- 0448US2024000737A1Substances for treatment of hyperuricaemiaSCANDIBIO THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 0548US2024366560A1Small molecule treatment of fatty liver disease and hccSCANDIEDGE THERAPEUTICS AB·Filed 2022·Application pending·0 cites
- 0647US2023270704A1Aminoacids for treatment of neurological disordersSCANDIBIO THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 0744US6933284B2Methods and tools for identifying compounds which modulate atherosclerosis by impacting LDL-proteoglycan bindingUNIV CALIFORNIA·Filed 2001·Granted Aug 23, 2005·0 cites·14 claims
- 0842US2022088044A1Substances for treatment of coronavirus infectionSCANDIBIO THERAPEUTICS AB·Filed 2020·Application pending·0 cites
- 0933US11034960B2PKLR inhibition in the treatment of NAFLD and HCCSCANDIEDGE THERAPEUTICS AB·Filed 2018·Granted Jun 15, 2021·0 cites·23 claims
- 1028US7038011B2Methods and tools for identifying compounds which modulate atherosclerosis by impacting LDL-proteoglycan bindingUNIV CALIFORNIA·Filed 2001·Granted May 2, 2006·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Jan Borén files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →